Eun Joo Roh

3.3k total citations · 1 hit paper
81 papers, 2.5k citations indexed

About

Eun Joo Roh is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Eun Joo Roh has authored 81 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 32 papers in Organic Chemistry and 23 papers in Oncology. Recurrent topics in Eun Joo Roh's work include Synthesis and biological activity (11 papers), Neuroscience and Neuropharmacology Research (10 papers) and Cancer therapeutics and mechanisms (9 papers). Eun Joo Roh is often cited by papers focused on Synthesis and biological activity (11 papers), Neuroscience and Neuropharmacology Research (10 papers) and Cancer therapeutics and mechanisms (9 papers). Eun Joo Roh collaborates with scholars based in South Korea, Egypt and Saudi Arabia. Eun Joo Roh's co-authors include Choong Eui Song, Ahmed Elkamhawy, Jung Hoon Choi, Sang‐gi Lee, Ae Nim Pae, Ahmed H.E. Hassan, C. Justin Lee, Ahmed A. Al‐Karmalawy, Hogyu Han and Marwa Sharaky and has published in prestigious journals such as Angewandte Chemie International Edition, Cancer Research and Chemical Communications.

In The Last Decade

Eun Joo Roh

79 papers receiving 2.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments

2023 214 citations Eun Joo Roh, Ahmed Elkamhawy et al. Biomedicine & Pharmacotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eun Joo Roh South Korea	27	1.1k	915	387	242	204	81	2.5k
Charles S. Elmore Sweden	23	462 0.4×	843 0.9×	60 0.2×	246 1.0×	114 0.6×	103	2.3k
Jun Mo China	26	971 0.9×	547 0.6×	114 0.3×	37 0.2×	192 0.9×	52	2.3k
Craig Jamieson United Kingdom	28	1.2k 1.2×	1.2k 1.3×	38 0.1×	111 0.5×	120 0.6×	84	2.5k
Shiqi Peng China	27	836 0.8×	1.2k 1.3×	55 0.1×	199 0.8×	239 1.2×	214	2.9k
Jean Pierre Bazureau France	25	1.6k 1.6×	601 0.7×	657 1.7×	52 0.2×	127 0.6×	109	2.4k
Rosa Amoroso Italy	28	941 0.9×	1.1k 1.2×	40 0.1×	149 0.6×	166 0.8×	124	2.3k
Makoto Wada Japan	29	1.5k 1.4×	862 0.9×	55 0.1×	187 0.8×	111 0.5×	157	3.0k
Masatoshi Shibuya Japan	43	2.6k 2.5×	2.7k 2.9×	104 0.3×	1.1k 4.7×	304 1.5×	144	6.9k
Jing Xu China	33	1.6k 1.5×	973 1.1×	39 0.1×	64 0.3×	305 1.5×	132	3.2k

Countries citing papers authored by Eun Joo Roh

Since Specialization

Citations

This map shows the geographic impact of Eun Joo Roh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eun Joo Roh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eun Joo Roh more than expected).

Fields of papers citing papers by Eun Joo Roh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eun Joo Roh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eun Joo Roh. The network helps show where Eun Joo Roh may publish in the future.

Co-authorship network of co-authors of Eun Joo Roh

This figure shows the co-authorship network connecting the top 25 collaborators of Eun Joo Roh. A scholar is included among the top collaborators of Eun Joo Roh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eun Joo Roh. Eun Joo Roh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alzain, Abdulrahim A., Wadah Osman, Ahmed Ashour, et al.. (2024). Integrating computational methods guided the discovery of phytochemicals as potential Pin1 inhibitors for cancer: pharmacophore modeling, molecular docking, MM-GBSA calculations and molecular dynamics studies. Frontiers in Chemistry. 12. 1339891–1339891. 8 indexed citations

Elmaaty, Ayman Abo, Islam Zaki, Ahmed A.E. Mourad, et al.. (2023). Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2′,3′:4,5]thiazolo[3,2- a ]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2205043–2205043. 28 indexed citations

Moon, Bongjin, Jin‐Young Hwang, Chiman Song, et al.. (2023). Novel potent blockers for TWIK-1/TREK-1 heterodimers as potential antidepressants. Biomedicine & Pharmacotherapy. 165. 115139–115139. 3 indexed citations

Park, Sujin, Yong‐Chan Kim, Eun Joo Roh, et al.. (2022). Design, Synthesis and Biological Evaluation of 1,3,5-Triazine Derivatives Targeting hA1 and hA3 Adenosine Receptor. Molecules. 27(13). 4016–4016. 5 indexed citations

Ammar, Usama M., Magda H. Abdellattif, Mohammed A. S. Abourehab, et al.. (2022). 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation. Life. 12(6). 876–876. 4 indexed citations

Elkamhawy, Ahmed, Jong‐Hyun Park, Ahmed H.E. Hassan, et al.. (2021). Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies. Bioorganic Chemistry. 115. 105233–105233. 12 indexed citations

Elkamhawy, Ahmed, Noha Gouda, Hossam Nada, et al.. (2021). Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress. Antioxidants. 10(10). 1604–1604. 26 indexed citations

Gouda, Noha, Jungsook Cho, Ae Nim Pae, et al.. (2021). Highly Potent, Selective, and Competitive Indole-Based MAO-B Inhibitors Protect PC12 Cells against 6-Hydroxydopamine- and Rotenone-Induced Oxidative Stress. Antioxidants. 10(10). 1641–1641. 24 indexed citations

Elkamhawy, Ahmed, et al.. (2021). Scaffold Repurposing of In-House Small Molecule Candidates Leads to Discovery of First-in-Class CDK-1/HER-2 Dual Inhibitors: In Vitro and In Silico Screening. Molecules. 26(17). 5324–5324. 11 indexed citations

10.

Al‐Sanea, Mohammad M., Ahmed Elkamhawy, Silvia Bua, et al.. (2019). Synthesis and biological evaluation of novel 3-(quinolin-4-ylamino)benzenesulfonamides as carbonic anhydrase isoforms I and II inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 34(1). 1457–1464. 25 indexed citations

11.

Elkamhawy, Ahmed, Ahmed H.E. Hassan, Yong Sup Lee, et al.. (2019). EGFR inhibitors from cancer to inflammation: Discovery of 4-fluoro-N-(4-(3-(trifluoromethyl)phenoxy)pyrimidin-5-yl)benzamide as a novel anti-inflammatory EGFR inhibitor. Bioorganic Chemistry. 86. 112–118. 34 indexed citations

12.

Kang, Seok‐Min, Jung Moo Lee, Ahmed Elkamhawy, et al.. (2018). Repositioning of the antipsychotic trifluoperazine: Synthesis, biological evaluation and in silico study of trifluoperazine analogs as anti-glioblastoma agents. European Journal of Medicinal Chemistry. 151. 186–198. 32 indexed citations

13.

Elkamhawy, Ahmed, et al.. (2017). Hit discovery of 4-amino- N -(4-(3-(trifluoromethyl)phenoxy)pyrimidin-5-yl)benzamide: A novel EGFR inhibitor from a designed small library. Bioorganic Chemistry. 75. 393–405. 25 indexed citations

14.

Elkamhawy, Ahmed, et al.. (2017). Synthesis and evaluation of new pyridyl/pyrazinyl thiourea derivatives: Neuroprotection against amyloid-β-induced toxicity. European Journal of Medicinal Chemistry. 141. 322–334. 23 indexed citations

15.

Kang, Seok‐Min, Jinpyo Hong, Jung Moo Lee, et al.. (2016). Trifluoperazine, a Well-Known Antipsychotic, Inhibits Glioblastoma Invasion by Binding to Calmodulin and Disinhibiting Calcium Release Channel IP3R. Molecular Cancer Therapeutics. 16(1). 217–227. 91 indexed citations

16.

Elkamhawy, Ahmed, Ae Nim Pae, Jin-Chul Heo, et al.. (2015). Discovery of potent and selective cytotoxic activity of new quinazoline-ureas against TMZ-resistant glioblastoma multiforme (GBM). European Journal of Medicinal Chemistry. 103. 210–222. 21 indexed citations

17.

Kim, Sora, Jin Kyo Jung, Young-Jae Kim, et al.. (2011). Discovery of piperidinyl aminopyrimidine derivatives as IKK-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(10). 3002–3006. 12 indexed citations

18.

Kang, Sang Soo, Kyung‐Seok Han, Bo Mi Ku, et al.. (2010). Caffeine-Mediated Inhibition of Calcium Release Channel Inositol 1,4,5-Trisphosphate Receptor Subtype 3 Blocks Glioblastoma Invasion and Extends Survival. Cancer Research. 70(3). 1173–1183. 153 indexed citations

19.

Oh, Soo‐Jin, et al.. (2008). Development of selective blockers for Ca2+-activated Cl- channel using Xenopus laevis oocytes with an improved drug screening strategy. Molecular Brain. 1(1). 14–14. 15 indexed citations

20.

Song, Choong Eui, et al.. (1995). Polymeric cinchona alkaloids for the heterogeneous catalytic asymmetric dihydroxylation of olefins: The influence of the polymer backbone polarity on the compatibility between polymer support and reaction medium. Tetrahedron Asymmetry. 6(11). 2687–2694. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact